InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the detailed record of transactions filed by Shepard Jay, Director. Insider active across 4 companies, notably INOVIO PHARMACEUTICALS, INC.. In total, 10 disclosures have been published. The latest transaction was filed on 1 June 2022 — Attribution. Regulator: SEC (Form 4). The full history is free.
Declarations10 total
021,571 shares0
Class A Common Stock
SEC:0001209191-22-033982:0·
18,000 shares
Common Stock
SEC:0001055726-22-000040:0·
4,274 shares
Common Stock
SEC:0001055726-22-000002·
4,274 shares
Common Stock
SEC:0001055726-22-000002:0·
022,766 shares0
Class A Common Stock
SEC:0001209191-21-038223·
022,766 shares0
Class A Common Stock
SEC:0001209191-21-038223:0·
012,376 shares0
Common Stock
SEC:0001628280-21-011359·
012,376 shares0
Common Stock
SEC:0001628280-21-011359:0·
8,700 shares
Common Stock
SEC:0001055726-21-000046·
8,700 shares
Common Stock
SEC:0001055726-21-000046:0·
10 of 10 declarations
About Shepard Jay
Jay Shepard serves as a Board Member at Inovio Pharmaceuticals, Inc. and Esperion Therapeutics, Inc. In this role, he oversees operations and participates in strategic decision-making. His expertise in the biopharmaceutical sector allows him to provide significant contributions to the board.
